ResMed (RMD) Tops Q2 EPS by 8c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $195.66 +2.30%
EPS Growth %: +13.3%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +13.3%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.81, $0.08 better than the analyst estimate of $2.73. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- J Capital Research cautious on Microchip: 'riding high on AI hype but looks weak'
- Crude Inventory Fell 6.1 Million Barrels Last Week, Says EIA
- Chemours reaches $450M settlement over PFAS pollution at four sites
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
